We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Caterpillar
CAT
$402B
| $262K | ﹤0.01% |
794
-187
| -19% | -$66.6K |
|
677
Ituran Location and Control
ITRN
$1.09B
| $255K | ﹤0.01% |
7,065
-7,629
| -52% | -$275K |
|
|
LAR
678
Lithium Argentina AG
LAR
$963M
| $253K | ﹤0.01% |
118,409
-3,853
| -3% | -$9.72K |
|
679
Resources Connection
RGP
$133M
| $253K | ﹤0.01% |
38,717
+288
| +0.7% | +$2.23K |
|
|
TRUE
680
DELISTED
TrueCar
TRUE
| $250K | ﹤0.01% |
158,524
+1,178
| +0.7% | +$3.27K |
|
681
Radcom
RDCM
$222M
| $249K | ﹤0.01% |
21,747
-5,338
| -20% | -$68.1K |
|
682
Manitowoc
MTW
$523M
| $248K | ﹤0.01% |
+28,841
| New | +$281K |
|
683
Immersion
IMMR
$256M
| $248K | ﹤0.01% |
32,679
+241
| +0.7% | +$1.98K |
|
684
AMN Healthcare
AMN
$1.3B
| $247K | ﹤0.01% |
10,086
-1,311,286
| -99% | -$33.7M |
|
685
Brilliant Earth
BRLT
$18M
| $246K | ﹤0.01% |
155,531
+1,155
| +0.7% | +$1.88K |
|
|
THR
686
DELISTED
Thermon Group Holdings
THR
| $244K | ﹤0.01% |
8,775
+66
| +0.8% | +$1.91K |
|
687
Lifecore Biomedical
LFCR
$163M
| $241K | ﹤0.01% |
+34,175
| New | +$212K |
|
688
Allient
ALNT
$1.47B
| $240K | ﹤0.01% |
10,935
-855
| -7% | -$21.2K |
|
689
Huntsman Corp
HUN
$2.06B
| $238K | ﹤0.01% |
129,631
+3,826
| +3% | +$65K |
|
690
Blue Bird Corp
BLBD
$2.41B
| $234K | ﹤0.01% |
7,221
-4,459
| -38% | -$163K |
|
691
Varex Imaging
VREX
$463M
| $223K | ﹤0.01% |
19,253
-578,509
| -97% | -$7.65M |
|
692
VTEX
VTEX
$718M
| $221K | ﹤0.01% |
43,661
+326
| +0.8% | +$1.85K |
|
693
RTX Corp
RTX
$294B
| $220K | ﹤0.01% |
1,663
-1,775
| -52% | -$225K |
|
|
TBI
694
Trueblue
TBI
$237M
| $218K | ﹤0.01% |
40,978
+9,433
| +30% | +$64.4K |
|
695
TechTarget
TTGT
$275M
| $202K | ﹤0.01% |
+13,640
| New | +$220K |
|
|
ZIMV
696
DELISTED
ZimVie
ZIMV
| $202K | ﹤0.01% |
18,680
+139
| +0.7% | +$1.83K |
|
|
HDSN
697
Hudson Technologies
HDSN
$263M
| $199K | ﹤0.01% |
32,272
+5,065
| +19% | +$29.8K |
|
698
Frontier Group Holdings
ULCC
$1.4B
| $150K | ﹤0.01% |
+34,599
| New | +$258K |
|
699
CarParts.com
PRTS
$39.7M
| $149K | ﹤0.01% |
+14,861
| New | +$163K |
|
|
NESRW
700
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
| $67.7K | ﹤0.01% |
+188,165
| New | +$75.5K |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.